Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Rowex Ltd, Newtown, Bantry, Co. Cork, Ireland
Melcam 7.5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Pale yellow coloured round, flat bevelled uncoated tablets with central break-line on one side and plain on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains 7.5 mg of meloxicam.
Excipient with known effect: Each tablet contains 40.9 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Meloxicam |
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators. |
| List of Excipients |
|---|
|
Maize starch |
PVC/PVDC aluminium blisters.
Packs of 10, 20, 30, 50, 60 or 100 tablets.
Not all pack sizes may be marketed.
Rowex Ltd, Newtown, Bantry, Co. Cork, Ireland
PA0711/060/001
Date of first authorisation: 19 November 2004
Date of last renewal: 31 October 2008
| Drug | Countries | |
|---|---|---|
| MELCAM | Hong Kong, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
